News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

 

Race influences survival in glioblastoma patients with KPS =?80 and associates with genetic markers of retinoic acid metabolism.

Al's Comment:
This study shows a very large racial disparity - this time favoring African Americans.  They identified a set of genes that differed between the two groups, which may be responsible.   This difference is larger than most clinical trials would report as a successful treatment. It may be worth reporting clinical trial results by race and/or this group of genes now.
Historically, African Americans have been way underrepresented in clinical trials – as shown by this study.  Out of almost 1,000 patients, only 6% were African American -  while in the USA African Americans make up about 13% of the population.   We are working to try to correct that – and other – disparities.  
 


Posted on: 02/13/2019

Race influences survival in glioblastoma patients with KPS ≥ 80 and associates with genetic markers of retinoic acid metabolism.

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740